Ching-Shih Chen
- Molecular Biology
- Pharmacology top 2%
- Genetics top 10%
- Organic Chemistry top 10%
- Oncology
- Co-authors
- Tsui‐Ting ChingVivek M. RangnekarXueqin SongMelanie P. DermanAlex TokerLewis C. CantleyJohn R. FalckKatherine Spokes
- Topics
- Histone Deacetylase Inhibitors Research (4 papers)Protein Kinase Regulation and GTPase Signaling (3 papers)Protein Degradation and Inhibitors (2 papers)
- Partner nations
- United StatesTaiwanIsrael
In The Last Decade
Ching-Shih Chen
11 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 89
- Molecular Biology 468
- Pharmacology 432
- Genetics 237
- Organic Chemistry 217
- Oncology 180
Countries citing papers authored by Ching-Shih Chen
This map shows the geographic impact of Ching-Shih Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ching-Shih Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ching-Shih Chen more than expected).
Fields of papers citing papers by Ching-Shih Chen
This network shows the impact of papers produced by Ching-Shih Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ching-Shih Chen. The network helps show where Ching-Shih Chen may publish in the future.
Co-authorship network of co-authors of Ching-Shih Chen
This figure shows the co-authorship network connecting the top 25 collaborators of Ching-Shih Chen. A scholar is included among the top collaborators of Ching-Shih Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ching-Shih Chen. Ching-Shih Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 26 | |
| 3 | 21 | |
| 4 | Effects of Histone Deacetylase Inhibitors on Modulating H3K4 Methylation Marks - A Novel Cross-Talk Mechanism between Histone-Modifying Enzymes. | 20 |
| 5 | 37 | |
| 6 | 48 | |
| 7 | 17 | |
| 8 | The Cyclooxygenase-2 Inhibitor Celecoxib Induces Apoptosis by Blocking Akt Activation in Human Prostate Cancer Cells Independently of Bcl-2breakdown → | 590 |
| 9 | 117 | |
| 10 | 67 | |
| 11 | 122 | |
| 12 | 32 |
About Ching-Shih Chen
Ching-Shih Chen is a scholar working on Oncology, Molecular Biology and Biochemistry, having authored 12 papers that have together received 1.1k indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (4 papers), Protein Kinase Regulation and GTPase Signaling (3 papers) and Protein Degradation and Inhibitors (2 papers). The work is most often cited by research in Pharmacology (432 citations), Biochemistry (74 citations) and Immunology and Allergy (55 citations). Ching-Shih Chen has collaborated with scholars based in United States, Taiwan and Israel. Frequent co-authors include Tsui‐Ting Ching, Vivek M. Rangnekar, Xueqin Song, Melanie P. Derman, Alex Toker, Lewis C. Cantley, John R. Falck, Katherine Spokes, Keng Lin and Helen L. Yin. Their work appears in journals such as Journal of Biological Chemistry, PLoS ONE and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.